Principal Financial Group Inc Bionano Genomics, Inc. Transaction History

Principal Financial Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$0.57 - $1.16 $1,762 - $3,586	-3,092 Reduced 3.89%	76,323 $46,000
Q1 2023 May 09, 2023	BUY	$1.06 - $1.97 $13,088 - $24,325	12,348 Added 18.41%	79,415 $88,000
Q4 2022 Feb 09, 2023	BUY	$1.4 - $25.4 $5,052 - $91,668	3,609 Added 5.69%	67,067 $97,000
Q3 2022 Nov 09, 2022	BUY	$0.36 - $36.0 $5,710 - $571,032	15,862 Added 33.33%	63,458 $116,000
Q2 2022 Aug 10, 2022	SELL	$12.3 - $27.3 $7.65 Million - $17 Million	-621,754 Reduced 92.89%	47,596 $66,000
Q1 2022 May 09, 2022	SELL	$16.6 - $32.3 $4.13 Million - $8.04 Million	-248,912 Reduced 27.11%	669,350 $1.73 Million
Q4 2021 Feb 09, 2022	BUY	$29.9 - $61.2 $24 Million - $49.2 Million	804,180 Added 704.91%	918,262 $2.75 Million
Q3 2021 Nov 09, 2021	BUY	$51.4 - $68.2 $260,803 - $346,046	5,074 Added 4.65%	114,082 $627,000
Q2 2021 Aug 10, 2021	BUY	$44.1 - $84.0 $4.81 Million - $9.16 Million	109,008 New	109,008 $0

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $133M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.